Literature DB >> 28382860

Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia.

Xuejing Song1, Xiucui Luo2, Quansheng Gao3, Yuhuan Wang4, Qing Gao5, Wei Long1.   

Abstract

BACKGROUND: Preeclampsia, a gestational disease characterized by hypertension and proteinuria twenty weeks into pregnancy, is one of the leading causes of fetal and maternal mortality. Although multiple genetic and environmental factors are found to be related to the preeclampsia risk, the pathogenic pathways remain largely undefined. The placenta plays a critical role in the fetal development by carrying out the barrier, fetal-maternal exchange, and endocrine functions during pregnancy. Accumulated data indicated that the expression of multiple long noncoding RNA (LncRNA) is dysregulated in preeclamptic placentas. Moreover, manipulation of LncRNA expression led to functional alterations in trophoblast cell cultures, including changes in proliferation, differentiation, apoptosis, and migration.
OBJECTIVE: This article reviews published data on this subject and provides detailed information on the regulation and function of LncRNAs IGF2/H19, MEG3, SPRY4-IT1, HOTAIR, MALAT1, and FLT1P1 and CEACAMP8 in placental trophoblasts. The potential mechanisms underlying the action of these LncRNAs are also discussed to facilitate a better understanding on the potential role of these LncRNAs for the pathogenesis of preeclampsia.
CONCLUSION: It is elaborated that some lncRNAs probably contribute to the pathogenesis of preeclampsia through methylation, Notch-EGFL7 signaling pathway and Wnt/β-catenin pathway. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  LncRNA; Preeclampsia; non-coding RNA; pathogenesis; placenta; trophoblast

Mesh:

Substances:

Year:  2017        PMID: 28382860     DOI: 10.2174/1389450118666170404160000

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  34 in total

1.  Human umbilical cord mesenchymal stem cell-derived exosome-mediated transfer of microRNA-133b boosts trophoblast cell proliferation, migration and invasion in preeclampsia by restricting SGK1.

Authors:  Dan Wang; Quan Na; Gui Yu Song; Leilei Wang
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

2.  Silencing lncRNA-DGCR5 increased trophoblast cell migration, invasion and tube formation, and inhibited cell apoptosis via targeting miR-454-3p/GADD45A axis.

Authors:  Yanlin Yang; Haixia Shang
Journal:  Mol Cell Biochem       Date:  2021-05-10       Impact factor: 3.396

3.  Overexpression of tissue factor pathway inhibitor 2 attenuates trophoblast proliferation and invasion in preeclampsia.

Authors:  Lili Zheng; Jing Huang; Yuan Su; Fang Wang; Hongfang Kong; Hong Xin
Journal:  Hum Cell       Date:  2020-03-04       Impact factor: 4.174

4.  LncRNA CRNDE regulates trophoblast cell proliferation, invasion, and migration via modulating miR-1277.

Authors:  Hua Zhu; Li Kong
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  A review of omics approaches to study preeclampsia.

Authors:  Paula A Benny; Fadhl M Alakwaa; Ryan J Schlueter; Cameron B Lassiter; Lana X Garmire
Journal:  Placenta       Date:  2020-01-22       Impact factor: 3.481

6.  Hsa_circ_0008726 regulates the proliferation, migration, and invasion of trophoblast cells in preeclampsia through modulating the miR-1290-LHX6 signaling pathway.

Authors:  Yongyan Zhang; Shuai Fang; Jiayi Wang; Siqian Chen; Rongrong Xuan
Journal:  J Clin Lab Anal       Date:  2022-06-13       Impact factor: 3.124

7.  Upregulation of PUM1 Expression in Preeclampsia Impairs Trophoblast Invasion by Negatively Regulating the Expression of the lncRNA HOTAIR.

Authors:  Yan Zhang; Xiao-Ying He; Shi Qin; Hui-Qin Mo; Xiao Li; Fan Wu; Jing Zhang; Xing Li; Lin Mao; Ya-Qing Peng; Yu-Na Guo; Yi Lin; Fu-Ju Tian
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

Review 8.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

Review 9.  Roles of noncoding RNAs in preeclampsia.

Authors:  Ningxia Sun; Shiting Qin; Lu Zhang; Shiguo Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

10.  Competing endogenous RNA expression profiling in pre-eclampsia identifies hsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia.

Authors:  Xiaopeng Hu; Junping Ao; Xinyue Li; Huijuan Zhang; Ji Wu; Weiwei Cheng
Journal:  Clin Epigenetics       Date:  2018-04-10       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.